Numpadit, Supaporn http://orcid.org/0000-0002-0374-4879
Ito, Chiaki
Nakaya, Takaaki
Hagiwara, Katsuro http://orcid.org/0000-0001-7545-7644
Funding for this research was provided by:
Rakuno Gakuen University (2019-2022)
Article History
Received: 7 December 2022
Accepted: 20 March 2023
First Online: 6 April 2023
Declarations
:
: The authors declare no conflict of interest.
: This study was performed in strict accordance with the recommendations of the Guidelines for Proper Conduct of Animal Experiments of the Science Council of Japan (ExternalRef removed kohyo/pdf/kohyo-20-k16-2e.pdf). The recombinant virus construction and use study was conducted with the approval of the Ethics Committee (Approval No.214). This study was conducted with the approval of the Ethics Committee in accordance with the guidelines for the management of experimental animals at Dairy Gakuen University (Approval No.: VH21B9).
: Ethics Committee review and approval were obtained for research using PBMCs derived from animals (dogs). No human or clinical sample was used in this study. Recombinant virus construction experiments were conducted in accordance with the guidelines of the Japanese Ministry of Education, Culture, Sports, Science, and Technology and with the approval of the Ethics Committee.